Vytrus Biotech, S.A. commences an Equity Buyback Plan under the authorization approved on June 30, 2021.
On May 4, 2022, the company announced a share repurchase program. Under the program, the company will repurchase 50,000 shares, which represent 0.70% of the share capital, for 162.5 million. The purpose of the treasury share repurchase program will be delivery to company directors, to meet the obligations to deliver the company's shares derived from agreement 4.6 of the Ordinary and Extraordinary General Shareholders' Meeting held in session on June 30, 2021, by which the granting of an incentive payable in company shares to certain employees and directors of the Company, subject to conditions of performance and permanence. The repurchase program will begin on May 5, 2022, and will remain in force until May 4, 2023.